Brief: Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Jan 23 (Reuters) - ECKERT & ZIEGLER EUZG.DE :
* ECKERT & ZIEGLER AND FULL-LIFE TECHNOLOGIES SIGN
ACTINIUM-225
SUPPLY AGREEMENT FOR NEXT GENERATION RADIOPHARMACEUTICALS
* AGREEMENT PROVIDES FULL-LIFE WITH ACCESS TO ECKERT &
ZIEGLER'S
HIGH-PURITY ACTINIUM-225, A RADIONUCLIDE FOR USE IN DEVELOPING
NEXT GENERATION OF THERAPEUTIC RADIOPHARMACEUTICALS
Source text for Eikon: ID:nEQ2dw72ta
Further company coverage: EUZG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth